机构地区:[1]山西医科大学第三医院(山西白求恩医院,山西医学科学院,同济山西医院)风湿免疫科,太原030032 [2]山西医科大学第五医院、山西省人民医院风湿免疫科,太原030012
出 处:《中华风湿病学杂志》2024年第11期819-828,I0003,共11页Chinese Journal of Rheumatology
基 金:山西省留学人员科技活动择优资助项目(20210003);山西省基础研究计划资助项目(202203021221266)。
摘 要:目的探讨人脐带间充质干细胞外泌体(hUCMSC-Exos)对类风湿关节炎(RA)滑膜成纤维细胞(FLSs)不同亚型组蛋白去乙酰化酶(HDAC)表达水平的影响,阐明hUCMSC-Exos通过调控HDAC影响类风湿关节炎(RA)FLSs凋亡的可能作用机制。方法分离培养并鉴定hUCMSCs及hUCMSC-Exos。实时荧光定量PCR(RT-qPCR)检测hUCMSC-Exos干预后FLSs中HDAC mRNA表达水平的变化,筛选出受影响最大的HDAC类型。免疫印迹法(Western Blot)检测空白对照组、hUCMSC组、hUCMSC-Exos组、曲古抑菌素A(Trichostatin A,TSA)组和HDAC1抑制剂(Pyroxamide)组中FLS HDAC1蛋白水平和NF-κB p65、磷酸化-NF-κB p65(Ser 536)的表达水平,明确hUCMSC-Exos对FLSs中HDAC表达和NF-κB活性的影响。流式细胞术检测hUCMSC-Exos对FLSs凋亡的影响。ELISA检测hUCMSC-Exos对FLSs分泌TNF-α、IL-6、IL-1β、IL-8的影响。利用流式细胞术及ELISA检测空白对照组、NF-κB抑制剂(吡咯烷二硫代氨基甲酸盐(PDTC)组、hUCMSC-Exos组和PDTC+hUCMSC-Exos共同干预组FLSs的细胞凋亡水平及促炎细胞因子的分泌水平,进一步探究抑制NF-κB是否影响hUCMSC-Exos对RA FLSs的调节作用。将所有符合正态分布的实验数据,采用独立样本t检验或单因素方差分析比较组间差异,进一步两两比较采用LSD-t检验。结果培养的原代hUCMSC为贴壁生长的纺锤型细胞,hUCMSC-Exos为茶托状膜性囊泡,均符合鉴定标准。hUCMSC-Exos可降低RA FLSs中HDCA1 mRNA[(0.932±0.091),t=2.19,P<0.001]和蛋白[(0.204±0.012),t=8.28,P<0.001]的表达水平,且抑制作用较hUCMSC(t=1.06,P=0.009)和HDAC1抑制剂(t=1.06,P=0.009)相比更强。hUCMSC-Exos使RA FLSs凋亡率升高[(48.68±0.84)%,t=12.33,P<0.001]。hUCMSC-Exos可降低RA FLSs上清液中TNF-α[(29.6±1.0)pg/ml,t=10.78,P<0.001]、IL-6[(20.1±0.7)pg/ml,t=7.96,P<0.001]、IL-1β[(9.28±0.23)pg/ml,t=6.14,P<0.001]、IL-8[(108.0±3.8)pg/ml,t=1.21,P<0.001]的分泌水平。hUCMSC-Exos可降低RA FLSs中p-NF-κB-p65/NF-κB-p65蛋白表达水平(0.Objective To investigate the effect of hUCMSC-exos on the expression levels of HDAC in different isotypes of RA FLSs,and to elucidate the possible mechanism of hUCMSC-exos on the apoptosis of RA FLSs by regulating HDAC.Methods hUCMSC and hUCMSC-Exos were isolated and identified.RT-qPCR was used to detect the changes in HDAC mRNA expression levels in FLSs after hUCMSC-Exos intervention,and the most affected HDAC types were identified.Western blot was used to detect the levels of FLS HDAC1 protein and the expression levels of NF-κB p65 and phospho-NF-κB p65(Ser 536)in the blank control group,hUCMSC group,hUCMSC-Exos group,Trichostatin A(TSA)group and HDAC1 Inhibitor(Pyroxamide)group.To investigate the effects of hUCMSC-Exos on HDAC expression and NF-κB activity in FLSs.Flow cytometry was used to detect the effect of hUCMSC-Exos on the apoptosis of FLSs.ELISA was used to detect the effects of hUCMSC-Exos on the secretion of TNF-α,IL-6,IL-1βand IL-8 by FLSs.Flow cytometry and ELISA were used to detect the apoptosis level and pro-inflammatory cytokine secretion level of RA FLSs in the blank control group,NF-κB Inhibitor(pyrrolidine dithiocarbamate(PDTC)group,hUCMSC-Exos group and PDTC+hUCMSC-Exos co-intervention group.Whether inhibition of NF-κB affects the regulatory effect of hUCMSC-Exos on RA FLSs was further explored.All experimental data conforming to the normal distribution were compared by one-way ANOVA.LSD-t test was used for pin-group comparison,and independent sample t test was used for two-sample comparison.Results Cultured primary hUCMSC were adherently grown spindle-shaped cells,and hUCMSC-Exos were saucer-shaped membranous vesicles,both of which met the identification criteria.hUCMSC-Exos reduced the expression level of HDCA1 mRNA[(0.932±0.091),t=2.19,P<0.001]and protein[(0.204±0.012),t=8.28,P<0.001]in RA FLSs,and the inhibitory effect was stronger than that of hUCMSC(t=1.09,P=0.009)and HDAC1(t=11.29,P=0.013)Inhibitor.hUCMSC-Exos increased the apoptosis rate of RA FLSs[(48.68±0.84)%,t=12.33,P<0
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...